Biotech seems to historically require a lot of iterations / failures before breakthroughs happen. I'm not sure the typical VC "startup" type expectations / spe

Biotech seems to historically require a lot of iterations / failures before breakthroughs happen. I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.